Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Lovastatin Loaded Solid Lipid Nanoparticles for Transdermal Delivery: In Vitro Characterization


Affiliations
1 Saras College of Pharmacy, Baghpat, Uttar Pradesh, 250622,, India
2 Glocal School of Pharmacy, Glocal University, Saharanpur, Uttar Pradesh 247121,, India
3 Department of Pharmaceutics, I.T.S College of Pharmacy, Murad Nagar, Ghaziabad, Uttar Pradesh 201206,, India
     

   Subscribe/Renew Journal


Lovastatin-loaded solid lipid nanoparticles were prepared by using glyceryl monostearate as lipid by solvent emulsification diffusion technique. The prepared SLNs were evaluated for particle size, shape, polydispersity index,zeta potential, percent drug loading, and in vitro release profile.The results reveal that the optimized SLNs are spherical, with a smooth surface and having particle size 298±1.1 nm, the PDI and zeta potential of optimized formulation was 0.42±0.09 and -19.1±0.81 MeV, respectively, the percent drug loading was 49.81±0.87. The optimized formulation follows Higuchi’s kinetics for drug release.

Keywords

Lovastatin, Zeta potential, Solid lipid nanoparticles.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Lovastatin. Available from:https://pubchem.ncbi.nlm.nih.gov/compound/Lovastatin. Accessed on 03.01.2021.

  • Davidson MH, Lukacsko P, Sun JX, Phillips G, Walters E, Sterman A, Niecestro R, Friedhoff L, A multiple-dose pharmacodynamic, safety, and pharmacokinetic comparison of extended- and immediate-release formulations of lovastatin. Clinical Therapeutics. 2002;24: 112–125.

  • Sowmya AT. Hypolipidemic activity of Mimosa pudica Linn on butter induced hyperlipidemia in rats. Asian Journal of Research in Pharmaceutical Sciences. 2011;1(4):123-126.

  • Gutierrez GE, Lalka D, Garrett IR, Rossini G, Mundy GR. Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations. Osteoporosis International. 2006;17: 1033-1042.

  • Martín-Jiménez T, Lindeblad M, Kapetanovic IM, Chen Y, Lyubimov A. Comparing pharmacokinetic and pharmacodynamic profiles in female rats orally exposed to lovastatin by gavage versus diet. Chemico-Biological Interactactions. 2008; 171: 142–151.

  • Jacobsen W, Kirchner G, Hallensleben K, Mancinelli L, Deters M, Hackbarth I, Baner K, Benet LZ, Sewing K, Christians U. Small intestinal metabolism of the 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor lovastatin and comparison with pravastatin. Journal of Pharmacology and Experimental Therapeutics. 1999; 291: 131-139.

  • Reyderman L, Kosoglou T, Boutros T, Seiberling M, Statkevich P. Pharmacokinetic interaction between ezetimibe and lovastatin in healthy volunteers. Current Medical Research and Opinion. 2004; 20: 1493–1500.

  • Gujar KN, Mathure D, Satpute PP, Awasthi R, Dua K, Madan JR. Skin targeting of oxiconazole nitrate loaded nanostructured lipid carrier gel for fungal infections. Pharmaceutical Nanotechnology. 2018; 6(3):192-200.

  • Wake PS, Kshirsagar MD. Design and characterization of solid lipid nanoparticle based transdermal drug delivery System. Asian Journal of Research in Pharmaceutical Sciences. 2017; 7(2): 87-91.

  • Han T, Das DB. Potential of combined ultrasound and microneedles for enhanced transdermal drug permeation: A review. European Journal of Pharmaceutics and Biopharmaceutics. 2015; 89: 312–328.

  • Jindal S, Kumar A, Goyal K, Awasthi R, Kulkarni GT. Lipid nanocarriers for dermal delivery of lutein. In: Rahman M, Beg S, Kumar V, Ahmad FJ (Editor). Nanomedicine for Bioactives. Springer Nature, Singapore. 2020. pp 341-366.

  • Wissing SA, Kayser O, Muiller RH. Solid lipid nanoparticles for parenteral drug delivery. Advanced Drug Delivery Reviews. 2004; 56: 1257-1272.

  • Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery: A review of the state of the art. European Journal of Pharmaceutics and Biopharmaceutics. 2000;50:161-77.

  • Yi Fan Luo, Da Wei Chen, Li Xiang Ren, Xiu Li Zhao, Qin J. Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability. Journal of Controlled Release. 2006;114:53-9.

  • Louise B. Jensena, Emily Magnusssona, Linda Gunnarssona. Corticosteroid solubility and lipid polarity control release from solid lipid nanoparticles. International Journal of Pharmaceutics. 2010; 390: 53–60.

  • Dingler A, Blum RP, Niehus H, Muller RH, Gohla S. Solid lipid nanoparticles (SLN/ Lipopearlst) a pharmaceutical and cosmetic carrier for the application of vitamin E in dermal products. Journal of Microencapsulation. 1999;16 (6): 751-767.

  • Sharma A, Dubey A, Yadav R. Solid lipid nanoparticles: A promising nanotechnology. Research Journal of Pharmaceutical Dosage Forms and Technology. 2011; 3(5): 167-175.

  • Borkar S, Shende Vikas, Chatap V, Sawant V, Suresh R, Dama G. Tamoxifen citrate loaded solid lipid nanoparticles- a novel approach in the treatment of ER+ breast cancer. Research Journal of Pharmaceutical Dosage Forms and Technology. 2009; 1(2): 143-149.

  • Wissing SA, Lippacher A, Muller RH. Investigations on the occlusive properties of solid lipid nanoparticles (SLN). Journal of Cosmetic Science. 2001;52: 313-324.

  • Shah AK, Date AA, Joshi MD, Patravale VB. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. International Journal of Pharmaceutics. 2007; 345:163-171.

  • Singh AP, Saraf SK, Saraf SA. SLN approach for nose-to-brain delivery of alprazolam. Drug Delivery and Translational Research, 2012; 2:498-507.

  • IngawaleGS, Goswami-Giri AS. Zeta potential of lantadene post alcoholic reflux method. Asian Journal of Research in Chemistry. 2013; 6(12): 1137-1139.

  • Khatak S, Mehta M, Awasthi R, Paudel KR, Hansbro NG, Hansbro PM, Dua K, Dureja H. Solid lipid nanoparticles containing anti-tubercular drugs attenuate the Mycobacterium marinum infection. Tuberculosis. 2020: 125: 102008.

  • Wake PS, KshirsagarMD. Compatibility study in-vitro drug release study of solid lipid nanoparticle based transdermal drug delivery system for rasagiline mesylate. Asian Journal of Research in Pharmaceutical Sciences. 2017; 7(2): 92-96.

  • Shah M, Pathak K. Solid lipid nanoparticles of simvastatin: pharmacokinetic and biodistribution studies on Swiss Albino mice. Research Journal of Pharmaceutical Dosage Forms and Technology. 2012; 4(6): 336-342.

  • Madan JR, Khobaragade S, Dua K, Awasthi R. Formulation, optimization and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast. Dermatologic Therapy. 2020; 33(3): e13317.

  • Ashok P, Meyyanathan SN, Jawahar NR. Vadivelan. Irbesartan formulation and evaluation of loaded solid lipid nanoparticles by microemulsion technique. Asian Journal of Pharmacy and Technology. 2020; 10(4):228-230.

  • Deshmukh AS. Solid lipid nanoparticles. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014; 6(4):282-285.

  • Satapathy T, Panda PK. Solid lipid nanoparticles: A novel carrier in drug delivery system. Research Journal of Pharmaceutical Dosage Forms and Technology. 2013; 5(2): 56-61.

  • Ranpise HA, Gujar KN, Pawar SC, Dua K, Awasthi R, Mathure D, Madan JR. Formulation, optimization and evaluation of ketoconazole loaded nanostructured lipid carrier gel for topical delivery. Drug Delivery Letters. 2020; 10(1): 61-71.

  • Mitri K, Shegokar R, Gohla S, Anselmi C, Muller RH,Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance. International Journal of Pharmaceutics. 2011; 414: 267-275.

  • Godara S, Lather V, Kirthana SV, Awasthi R, Pandita D. Lipid-PLGA hybrid nanoparticles of paclitaxel: Preparation, characterization, in vitro and in vivo evaluation. Materials Science and Engineering: C. 2020; 109:110576.

  • Mathure D, Madan JR, Awasthi R, Dua K, Gujar KN. Formulation and evaluation of nano structured lipid carriers for intranasal delivery of Buspirone hydrochloride. Research Journal of Pharmacy and Technology. 2021; 14(2): 585-593.


Abstract Views: 93

PDF Views: 0




  • Lovastatin Loaded Solid Lipid Nanoparticles for Transdermal Delivery: In Vitro Characterization

Abstract Views: 93  |  PDF Views: 0

Authors

Dinesh Kumar Gupta
Saras College of Pharmacy, Baghpat, Uttar Pradesh, 250622,, India
Satish Kumar Sharma
Glocal School of Pharmacy, Glocal University, Saharanpur, Uttar Pradesh 247121,, India
Praveen Kumar Gaur
Department of Pharmaceutics, I.T.S College of Pharmacy, Murad Nagar, Ghaziabad, Uttar Pradesh 201206,, India
Alok Pratap Singh
Department of Pharmaceutics, I.T.S College of Pharmacy, Murad Nagar, Ghaziabad, Uttar Pradesh 201206,, India

Abstract


Lovastatin-loaded solid lipid nanoparticles were prepared by using glyceryl monostearate as lipid by solvent emulsification diffusion technique. The prepared SLNs were evaluated for particle size, shape, polydispersity index,zeta potential, percent drug loading, and in vitro release profile.The results reveal that the optimized SLNs are spherical, with a smooth surface and having particle size 298±1.1 nm, the PDI and zeta potential of optimized formulation was 0.42±0.09 and -19.1±0.81 MeV, respectively, the percent drug loading was 49.81±0.87. The optimized formulation follows Higuchi’s kinetics for drug release.

Keywords


Lovastatin, Zeta potential, Solid lipid nanoparticles.

References